Werkgroep Cardiologische centra Nederland

AVANT GARDE (Completed)

A randomized, double-blind, parallel-group, placebocontrolled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in stabilized patients post acute coronary syndromes
Medicine
aliskiren
Population
ASCVD
Phase
II
Starting year
2006